Page 51

She turned her monitor toward me. The overnight results occupied most of the screen. I stepped closer. I wasn’t sure I was reading them correctly. When I looked into Priya’s eyes, I realized I was.

“When did these come in?” I asked.

“Eleven forty-seven.” She paused. “I’ve been here since midnight.”

“Why didn’t you call me?”

“Because I wanted to be sure first. I reran the assay and confirmed it.” She showed me both data sets. “Look at the difference between the experimental group and the controls.”

Aurora had always outperformed other molecules that inhibited the same pathway, and no one understood why. We had often thought our methodology was more developed. The sample preparation, the timing, even the type of water we used when making the buffers. We had hypothesized almost everything except the variable that mattered. Overnight, Priya had identified it. Unlike the earlier drugs, Aurora did not starve the tissue of oxygen the way they did.

The therapeutic implication was immediate and significant. It was not a cure. It was, however, an explanation. In the clinical trials of the earlier molecules, some patients had reported feeling lightheaded or faint immediately after treatment, while others experienced more severe side effects. Those reactions had limited how much of the drugs could be given, how long treatment could continue, and how frequently patients could receive it.

Aurora’s success wasn’t an accident. If the effect held, it could mean higher doses for longer periods without the same damage to the surrounding tissue.

“Priya,” I said.

“I know.” Her voice was careful in the way of someone handling something fragile. “I’ve analyzed the data in three different ways. It is consistent.”

I looked at her and nodded. She exhaled. Everything continued around us with the same rhythm. Blackwood Hall carried on, unaware.

“Pull Mateo in,” I said. “Let’s run a full replication before we say anything to anyone.”

I looked at her. “Do you understand what you just did?”

Priya stared at her monitor.

“You found the thing none of us thought to look for.”

* * *

By mid-afternoon, the news of the breakthrough spread through the research wing. The latest replication run was completed shortly after two o’clock, confirming what Priya had already found.

I asked her to come to my office. She came in carrying a notebook, closed the door behind her, then sat.

“The International Oncology Congress is in Vienna next spring,” I said.

She nodded. “I know.”

“The abstract deadline is in three weeks. I think this should be presented there. I’d like you to do it.”

She didn’t answer.

“The entire team will be listed as co-authors,” I continued. “Aurora belongs to all of us. But this discovery belongs to you.”

She shook her head almost immediately. “It should be you.”

“You stayed here all night making sure you were right. You found something none of us thought to measure. The recognition belongs to the person who earned it.”

She looked down at her hands. “I’ve never presented at a conference that large. If I’m wrong in front of that room, it isn’t my name that suffers. It’s Aurora’s.”

“We have validated the method and used the appropriate controls. The results are scientifically sound. A room of fifty or a room of fifty thousand, the presentation is the same. I have absolutely no doubt that you will do well.”

She smiled despite herself. “I have never been to Vienna.”

“I think you will enjoy it.”

“Vienna in the spring,” she said, warming to the idea. “Old hotels. Chandeliers. Room service on actual china.”